[go: up one dir, main page]

UY37100A - Vacunas de fmdv vectorizadas con adenovirus recombinantes y usos de las mismas - Google Patents

Vacunas de fmdv vectorizadas con adenovirus recombinantes y usos de las mismas

Info

Publication number
UY37100A
UY37100A UY0001037100A UY37100A UY37100A UY 37100 A UY37100 A UY 37100A UY 0001037100 A UY0001037100 A UY 0001037100A UY 37100 A UY37100 A UY 37100A UY 37100 A UY37100 A UY 37100A
Authority
UY
Uruguay
Prior art keywords
vectorized
fmdv
same
recombinant adenovirus
fmdv vaccines
Prior art date
Application number
UY0001037100A
Other languages
English (en)
Inventor
Justin Widener
Leszlie Woodyward
Leonardo Siger
Douglas Brough
Damodar Ettyreddy
Jason Gall
Duncan McVEY
Tom Burrage
John Schutta Christopher
Original Assignee
Merial Inc
Genvec Inc
The Government Of The Us Secretary Of Homeland Security
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc, Genvec Inc, The Government Of The Us Secretary Of Homeland Security filed Critical Merial Inc
Publication of UY37100A publication Critical patent/UY37100A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/135—Foot- and mouth-disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/106—Plasmid DNA for vertebrates
    • C12N2800/107—Plasmid DNA for vertebrates for mammalian
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/70—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención abarca vacunas o composiciones de FMDV. Se describen vectores recombinantes que codifican y que expresan antígenos, epitopes o inmunógenos de FMDV que se pueden usar para proteger animales, en particular ovinos, bovinos, caprinos, o porcinos, contra el FMDV.
UY0001037100A 2016-01-29 2017-01-30 Vacunas de fmdv vectorizadas con adenovirus recombinantes y usos de las mismas UY37100A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662288540P 2016-01-29 2016-01-29

Publications (1)

Publication Number Publication Date
UY37100A true UY37100A (es) 2017-08-31

Family

ID=58191570

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001037100A UY37100A (es) 2016-01-29 2017-01-30 Vacunas de fmdv vectorizadas con adenovirus recombinantes y usos de las mismas

Country Status (21)

Country Link
US (2) US10188721B2 (es)
EP (1) EP3408398B1 (es)
JP (1) JP6878464B2 (es)
KR (1) KR102283303B1 (es)
CN (1) CN108779474B (es)
AR (1) AR110458A1 (es)
AU (1) AU2017212813B2 (es)
CA (1) CA3012802A1 (es)
CY (1) CY1124218T1 (es)
DK (1) DK3408398T3 (es)
ES (1) ES2787902T3 (es)
JO (1) JOP20170022B1 (es)
MA (1) MA43195B1 (es)
MX (1) MX391908B (es)
NZ (1) NZ744786A (es)
PT (1) PT3408398T (es)
RU (1) RU2725495C9 (es)
TW (1) TWI760322B (es)
UY (1) UY37100A (es)
WO (1) WO2017132666A1 (es)
ZA (1) ZA201804965B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI760322B (zh) * 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途
EP3824906A1 (en) 2016-12-21 2021-05-26 Amgen Inc. Anti-tnf alpha antibody formulations
CN108997493B (zh) * 2018-08-15 2019-07-09 中国农业科学院兰州兽医研究所 一种全牛源o型口蹄疫病毒广谱中和抗体的制备方法
US11582956B2 (en) * 2018-09-27 2023-02-21 The United States Of America, As Represented By The Secretary Of Agriculture Recombinant adenovirus-based interferon biotherapeutics in swine
CN113817068B (zh) * 2020-12-24 2024-01-30 北京微佰生物科技有限公司 一种以人复制缺陷型重组腺病毒为载体的o型口蹄疫疫苗
CN114957480B (zh) * 2021-02-23 2024-01-30 北京微佰生物科技有限公司 一种以人复制缺陷型重组腺病毒为载体的a型口蹄疫疫苗
CN112852760A (zh) * 2021-03-04 2021-05-28 温氏食品集团股份有限公司 重组鸭肠炎病毒及其应用
US12453767B2 (en) 2021-08-18 2025-10-28 The United States Of America, As Represented By The Secretary Of Agriculture Development of mosaic vaccines against foot and mouth disease virus serotype O
JP7757599B2 (ja) * 2021-11-17 2025-10-22 リパブリック オブ コリア（アニマル アンド プラント クオレンティン エージェンシー） 強力な適応免疫反応を誘導し且つ母体移行抗体の干渉を克服する組換え口蹄疫ａ型ウイルス、及びそれを含む口蹄疫ワクチン組成物
KR102770876B1 (ko) * 2022-02-14 2025-02-26 대한민국 구제역바이러스 구조단백질 vp0 부위에 특이적으로 결합하는 항체 또는 이의 항원 결합 단편, 및 이들의 용도
KR20240098952A (ko) 2022-12-21 2024-06-28 대한민국(농림축산식품부 농림축산검역본부장) 구제역백신의 무침 피내 접종방법
KR20240098951A (ko) 2022-12-21 2024-06-28 대한민국(농림축산식품부 농림축산검역본부장) 초기 방어가 가능한 피내접종용 구제역 백신 조성물
KR20240098948A (ko) 2022-12-21 2024-06-28 대한민국(농림축산식품부 농림축산검역본부장) 장기 면역 유도가 가능한 피내접종용 구제역 백신 조성물
US20250134984A1 (en) * 2023-10-26 2025-05-01 The United States Of America, As Represented By The Secretary Of Agriculture Development of mosaic vaccines against foot and mouth disease virus serotype asia
CN119899854B (zh) * 2024-12-30 2025-12-09 中国兽医药品监察所 一种猪口蹄疫o型和a型二价病毒样颗粒的制备方法和应用
CN119979483A (zh) * 2025-02-10 2025-05-13 华中农业大学 一种自发产生病毒样颗粒的重组腺病毒制备方法及应用

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US5505941A (en) 1981-12-24 1996-04-09 Health Research, Inc. Recombinant avipox virus and method to induce an immune response
US4708871A (en) 1983-03-08 1987-11-24 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
DE3584341D1 (de) 1984-08-24 1991-11-14 Upjohn Co Rekombinante dna-verbindungen und expression von polypeptiden wie tpa.
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4968615A (en) 1985-12-18 1990-11-06 Ciba-Geigy Corporation Deoxyribonucleic acid segment from a virus
US4963481A (en) 1985-12-18 1990-10-16 Genetics Institute Inc Promoter system
EP0260148A3 (en) 1986-09-12 1989-06-07 Genentech, Inc. Improved recombinant expression method, vector and transformed cells
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
DE3743138A1 (de) 1987-12-18 1989-09-14 Mayr Christian Gmbh & Co Kg Schleifringlose, elektromagnetische ueberlastkupplung
ZA915593B (en) 1990-07-24 1993-03-31 Novagene Inc Herpesvirus-based viral vector which expresses a foot and mounth disease virus epitope on the surface of virus-infected cells and on the surface of virus particles,and vaccine against foot and mounth disease containing the same
AU672359B2 (en) 1991-03-07 1996-10-03 Virogenetics Corporation Genetically engineered vaccine strain
EP0826063A1 (en) 1995-04-25 1998-03-04 Vical Incorporated Single-vial formulations of dna/lipid complexes
US5846946A (en) 1996-06-14 1998-12-08 Pasteur Merieux Serums Et Vaccins Compositions and methods for administering Borrelia DNA
FR2751226B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies du cheval
FR2751225B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique aviaire
FR2751224B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
FR2751227B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
FR2751229B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
FR2751228B1 (fr) 1996-07-19 1998-11-20 Rhone Merieux Vaccin polynucleotidique bovin pour voie intradermique
ATE292980T1 (de) 1996-10-11 2005-04-15 Univ California Immunostimulierende oligonucleotidekonjugate
CA2294793A1 (fr) 1997-06-30 1999-01-14 Rhone-Poulenc Rorer S.A. Amelioration du transfert d'acide nucleique dans le muscle strie et combinaison permettant la mise en oeuvre du procede
FR2778858B1 (fr) 1998-05-20 2000-06-16 Oreal Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique
US6107021A (en) * 1998-06-20 2000-08-22 United Biomedical, Inc. Synthetic peptide vaccines for foot-and-mouth disease
FR2801607B1 (fr) 1999-11-26 2001-12-28 Merial Sas Pneumovirus du canard et vaccins correspondants
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
FR2810888B1 (fr) 2000-06-29 2004-07-30 Merial Sas Vaccin contre la fievre aphteuse
RU2294211C2 (ru) * 2001-01-19 2007-02-27 Цитос Байотекнолоджи Аг Композиция и способ для иммунизации, способ продуцирования неприродного, упорядоченного и повторяющегося массива антигенов
JP2006528647A (ja) 2003-07-24 2006-12-21 メリアル リミテッド 新規ワクチン製剤
DK1773387T3 (da) * 2004-06-25 2013-07-15 Merial Ltd Avipox-rekombinanter der udtrykker mund- og klovesyge-virusgener
US7691368B2 (en) 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
BRPI0618441B8 (pt) 2005-11-10 2021-07-27 Genvec Inc vetor adenoviral
CN107213461B (zh) 2009-09-10 2022-03-15 勃林格殷格翰动物保健美国公司 包含含有皂苷的佐剂的新疫苗制剂
US9345759B2 (en) * 2010-03-12 2016-05-24 Merial, Inc. Bluetongue virus recombinant vaccines and uses thereof
US8765141B2 (en) * 2010-07-01 2014-07-01 The United States Of America, As Represented By The Secretary Of Agriculture Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
RU2745373C2 (ru) 2014-09-23 2021-03-24 БЁРИНГЕР ИНГЕЛЬХАЙМ ЭНИМАЛ ХЕЛТ ЮЭсЭй ИНК. Рекомбинантные вакцины от fmdv и их применение
TWI760322B (zh) * 2016-01-29 2022-04-11 美商百靈佳殷格翰動物保健美國有限公司 重組腺病毒載體裝載之fmdv疫苗及其用途

Also Published As

Publication number Publication date
DK3408398T3 (da) 2020-02-10
ZA201804965B (en) 2019-07-31
BR112018015345A2 (pt) 2018-12-18
AU2017212813B2 (en) 2020-10-08
TW201735944A (zh) 2017-10-16
US20170216422A1 (en) 2017-08-03
AU2017212813A1 (en) 2018-08-16
RU2018130813A3 (es) 2020-03-03
KR102283303B1 (ko) 2021-07-28
NZ744786A (en) 2020-05-29
US20190134183A1 (en) 2019-05-09
RU2725495C9 (ru) 2020-09-01
MA43195B1 (fr) 2020-11-30
AR110458A1 (es) 2019-04-03
CY1124218T1 (el) 2022-11-25
US10493144B2 (en) 2019-12-03
US10188721B2 (en) 2019-01-29
JP6878464B2 (ja) 2021-05-26
CN108779474B (zh) 2022-10-18
MX391908B (es) 2025-03-21
JP2019507184A (ja) 2019-03-14
EP3408398B1 (en) 2019-11-27
EP3408398A1 (en) 2018-12-05
MA43195A1 (fr) 2019-04-30
CN108779474A (zh) 2018-11-09
CA3012802A1 (en) 2017-08-03
TWI760322B (zh) 2022-04-11
RU2018130813A (ru) 2020-03-03
BR112018015345A8 (pt) 2022-06-28
KR20180121896A (ko) 2018-11-09
PT3408398T (pt) 2020-02-25
RU2725495C2 (ru) 2020-07-02
MX2018009244A (es) 2019-07-10
JOP20170022B1 (ar) 2021-08-17
WO2017132666A1 (en) 2017-08-03
ES2787902T3 (es) 2020-10-19

Similar Documents

Publication Publication Date Title
UY37100A (es) Vacunas de fmdv vectorizadas con adenovirus recombinantes y usos de las mismas
MX2017003712A (es) Vacunas recombinantes contra fmdv y sus usos.
CO2018004564A2 (es) Genes de ataxia de friedreich modificados y vectores para terapia génica
CL2019003805A1 (es) Composiciones inmunógenas de senecavirus a y métodos de éstas.
BR112012023046A2 (pt) vacinas de vírus de febre aftosa recombinantes e seus respectivos usos
MX2018005315A (es) Composiciones y metodos para el tratamiento del cancer.
UY36995A (es) Proteínas de fusión de e2 y fmdv y sus usos
EA201790294A1 (ru) Средства на основе флагеллина и применения, включающие эффективную вакцинацию
AR105470A1 (es) Métodos para inducir una respuesta inmune
AR102657A1 (es) Composición para tratar telas
BR112019010275A2 (pt) adenovírus recombinante, composição, uso do adenovírus ou composição, método de induzir uma resposta imune em um paciente, e, adenovírus de símio não humano
MX2017011246A (es) Composiciones a base de listeria que comprenden un sistema de expresion de minigen peptidico y metodos de uso de estas.
MX378368B (es) Receptores de antigeno y usos de los mismos.
MX2017003121A (es) Formulaciones de anticuerpos.
MX2023001540A (es) Vacunas contra el cancer y metodos de tratamiento que las utilizan.
AR080313A1 (es) Composiciones de virus de moquillo canino (cdv) recombinante y sus usos
CL2019000032A1 (es) Uso de oxido de aleno sintasa para la preservación de semen y la reproducción asistida (divisional solicitud 201603067)
PE20190397A1 (es) Virus de enteritis de pato y usos del mismo
CO2020006907A2 (es) Péptidos antimicrobianos y métodos para usarlos
ECSP19008417A (es) Anticuerpos con inmunogenicidad baja y usos de estos
MX381252B (es) Virus de la enteritis del pato y usos del mismo.
MX386989B (es) Agente estimulador del receptor 5-hidroxitriptamina 1b para reparación de piel y/o cabello.
CL2016001906A1 (es) Vacunas contra el reovirus aviar.
UY36328A (es) Vacunas de fmdv recombinante y usos de las mismas
UY36860A (es) Vacunas recombinantes contra el calicivirus felino (fcv) y sus usos

Legal Events

Date Code Title Description
110 Patent granted

Effective date: 20240201